News

Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...
STAT1d
That was fast: Vinay Prasad is back at CBER
Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...
FDA Rehires Controversial Biologics Chief Just Days After Trump Fired Him
Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...
MedPage Today1d
Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE
Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...
STAT1d
Pharmalittle: We’re reading about Prasad’s return to FDA, a journal sparring with RFK Jr., and more
Plus more pharma news from the Pharmalittle newsletter.
Stocktwits on MSN1d
Trump Ally Laura Loomer Calls Vinay Prasad A ‘Marxist Trojan Horse’ After FDA Rehiring, Slams NASA For Dropping Isaacman
U.S. President Donald Trump's ally and far-right political activist, Laura Loomer, alleged on Sunday that the rehiring of ...
Biotech sector slips amid reported return of ousted FDA official
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...